SMME MAGAZINE

GET A QUOTE

Roche to buy biopharmaceutical firm 89bio in $3.5bn deal

Karina

·

·

The acquisition will bolster the Swiss pharmaceutical giant’s pipeline of treatments for cardiovascular, renal, and metabolic diseases.

Karina

Leave a Reply

Your email address will not be published. Required fields are marked *

Powered by
►
Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.
None
►
Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.
None
►
Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.
None
►
Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.
None
Powered by